<PAGE> 1
----------------------------
OMB APPROVAL
----------------------------
OMB Number 3235-0145
Expires: December 31, 1997
Estimated average burden
hours to perform .....14.90
----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------------
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ____)*
Bionutrics, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
090946 10 4
(CUSIP Number)
Ronald H. Lane, 2425 E. Camelback Road, Suite 650,
Phoenix, Arizona 85016 (602) 508-0112
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
January 12, 1999
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box *.
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC 1746 (12-91)
<PAGE> 2
- --------------------- -----------------
CUSIP NO. 090946 10 4 13D PAGE 2 OF 6 PAGES
- --------------------- -----------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William M. McCormick
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) |_|
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
1,030,834(1)(2)
NUMBER OF -----------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY 50,000
OWNED BY -----------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 1,030,834(1)(2)
PERSONAL WITH -----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
50,000
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,080,834
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|_|
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.0477%(3)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
See Page 6 for footnotes.
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE,
RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF
THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE> 3
- --------------------- -----------------
CUSIP NO. 090946 10 4 13D PAGE 3 OF 6 PAGES
- --------------------- -----------------
ITEM 1. SECURITY AND ISSUER
Name of Issuer: Bionutrics, Inc.
2425 E. Camelback Road, Suite 650
Phoenix, Arizona 85016
Equity Security: Common Stock
ITEM 2. IDENTITY AND BACKGROUND
(a) Name: William M. McCormick
(b) Residence or business address:
9 Pecksland Road
Greenwich, Connecticut 06831
(c) Present principal occupation or employment and the name,
principal business and address of any corporation or other
organization in which such employment is conducted:
Investor
(d) During the last five years, the Reporting Person has not been
convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors);
(e) During the last five years, the Reporting Person was not a
party to a civil proceeding of a judicial or administrative
body of competent jurisdiction and as a result of such
proceeding was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities
laws or finding any violation with respect to such laws.
(f) Citizenship: United States
<PAGE> 4
- --------------------- -----------------
CUSIP NO. 090946 10 4 13D PAGE 4 OF 6 PAGES
- --------------------- -----------------
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The Reporting Person purchased the securities reported with personal
funds, except for 6,667 options granted for no consideration and 100,000 shares
granted as compensation for services. The total consideration paid for shares
and warrants, including for those held by his spouse and minor children, is
$1,293,750.
ITEM 4. PURPOSE OF TRANSACTION
The Reporting Person's transactions in the Issuer's securities are for
investment purposes.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) The aggregate number of shares of Common Stock beneficially
owned by the reporting person is 1,080,834 shares, which
represents 5.0%(3) of the total Common Stock outstanding. This
number includes an aggregate of 706,667 shares of Common Stock
issuable upon exercise of currently exercisable warrants and
options.
(b) The Reporting Person has sole voting and dispositive power
over 1,030,834 shares of Common Stock beneficially owned of
which 25,000 are held by minor children and as to which he
disclaims beneficial ownership. This number includes currently
exercisable warrants and options to acquire an aggregate of
706,667 shares of Common Stock. The Reporting Person has
shared voting and dispositive power with his wife over 50,000
shares of Common Stock as to which the Reporting Person
disclaims beneficial ownership.
(c) The reporting person effected the following transactions
within 60 days of March 3, 1999:
100,000 shares granted as compensation.
(d) Not applicable.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Not applicable.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Not applicable.
<PAGE> 5
- --------------------- -----------------
CUSIP NO. 090946 10 4 13D PAGE 5 OF 6 PAGES
- --------------------- -----------------
FOOTNOTES:
(1) Does not include 50,000 shares of Common Stock held by the Reporting
Person's wife with regard to which the Reporting Person disclaims
beneficial ownership.
(2) Includes 25,000 shares of Common Stock held by the Reporting Person's minor
children with regard to which the Reporting Person disclaims beneficial
ownership.
(3) The calculation of the percent of ownership is based upon 20,705,732 shares
of Common Stock outstanding at February 12, 1999 plus 706,667 of options
and warrants currently exercisable.
<PAGE> 6
- --------------------- -----------------
CUSIP NO. 090946 10 4 13D PAGE 6 OF 6 PAGES
- --------------------- -----------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
March 3, 1999 /s/ William McCormick
---------------------------------------
William McCormick
The original statement shall be signed by each person on whose behalf
the statement is filed or his authorized representative. If the statement is
signed on behalf of a person by his authorized representative (other than an
executive officer or general partner of this filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE
FEDERAL CRIMINAL VIOLATIONS
(SEE 18 U.S.C. 1001)
